CME Group Inc. (NASDAQ:CME) Shares Acquired by Baldwin Brothers LLC MA

Posted by on Apr 9th, 2023

Baldwin Brothers LLC MA boosted its position in CME Group Inc. (NASDAQ:CME – Get Rating) by 10.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 880 shares of the financial services provider’s stock after acquiring an additional 85 shares during the quarter. Baldwin Brothers LLC MA’s holdings in CME Group were worth $148,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CME. RB Capital Management LLC grew its stake in CME Group by 11.4% during the first quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock worth $338,000 after buying an additional 145 shares during the period. Prudential PLC acquired a new position in shares of CME Group during the 1st quarter valued at $1,709,000. Cetera Investment Advisers boosted its position in CME Group by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock worth $829,000 after purchasing an additional 190 shares during the period. Sequoia Financial Advisors LLC acquired a new stake in CME Group in the 1st quarter valued at $281,000. Finally, Candriam Luxembourg S.C.A. raised its position in CME Group by 9.5% in the first quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock valued at $6,001,000 after purchasing an additional 2,181 shares during the period. Hedge funds and other institutional investors own 85.09% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $195.10 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.01 and a current ratio of 1.01. The company’s 50-day simple moving average is $184.59 and its 200-day simple moving average is $177.96. CME Group Inc. has a one year low of $166.54 and a one year high of $247.01. The stock has a market capitalization of $70.18 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 6.22 and a beta of 0.41.

CME Group (NASDAQ:CME – Get Rating) last issued its quarterly earnings results on Wednesday, February 8th. The financial services provider reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.02. CME Group had a return on equity of 10.43% and a net margin of 53.61%. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the previous year, the business earned $1.66 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. Equities analysts anticipate that CME Group Inc. will post 8.46 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 27th. Shareholders of record on Friday, March 10th were issued a dividend of $1.10 per share. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.26%. This is a boost from CME Group’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend was Thursday, March 9th. CME Group’s dividend payout ratio is 59.54%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Citigroup decreased their target price on CME Group from $214.29 to $210.00 in a research report on Thursday, January 12th. Oppenheimer decreased their price target on CME Group from $218.00 to $213.00 and set an “outperform” rating for the company in a report on Thursday, January 19th. UBS Group dropped their price objective on shares of CME Group from $226.00 to $220.00 in a research note on Thursday, January 5th. StockNews.com started coverage on shares of CME Group in a research note on Thursday, March 16th. They issued a “hold” rating for the company. Finally, Rosenblatt Securities reaffirmed a “sell” rating and set a $161.00 price target on shares of CME Group in a report on Wednesday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $219.83.

About CME Group

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Get Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.